NCT01855490View on ClinicalTrials.gov

Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

October 31, 2013

Conditions
Type 1 Diabetes
Interventions
DRUG

Exenatide

Trial Locations (1)

06519

Yale School of Medicine, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT01855490 - Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes | Biotech Hunter | Biotech Hunter